AdipoSeeds Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Later Stage VC
- Investors
-
15
AdipoSeeds General Information
Description
Developer of an allogeneic platelet product derived from human adipose tissue, designed to address platelet shortages and provide an alternative source of platelets for medical treatments. The company offers a technology to produce platelets from mesenchymal stem cells without complex and costly gene transfer, enabling biotechnology companies to use adipose-derived platelets in blood products and wound care medicines.
Contact Information
Website
www.adiposeeds.co.jp/enCorporate Office
- 35 Shinanomachi
- Keio University, School of Medicine, Research Park 9N2, Shibuya-ku
- Tokyo, 160-8582
- Japan
Corporate Office
- 35 Shinanomachi
- Keio University, School of Medicine, Research Park 9N2, Shibuya-ku
- Tokyo, 160-8582
- Japan
AdipoSeeds Timeline
AdipoSeeds Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 16-Oct-2026 | Completed | Pre-Clinical Trials | |||
| 5. Later Stage VC | 12-Dec-2022 | Completed | Pre-Clinical Trials | |||
| 4. Early Stage VC | 16-Oct-2020 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 01-Nov-2019 | Completed | Startup | |||
| 2. Early Stage VC | 20-Dec-2017 | Completed | Startup | |||
| 1. University Spin-Out | 07-Jul-2016 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AdipoSeeds Patents
AdipoSeeds Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026150938-A1 | Prevention or treatment of graft versus host disease using platelets produced from adipose tissue-derived mesenchymal stem cells | Pending | 10-Jan-2025 | ||
| WO-2026018855-A1 | Method for evaluating platelet function | Pending | 18-Jul-2024 | ||
| EP-4792820-A1 | Method for producing platelet-rich plasma | Pending | 12-Oct-2023 | ||
| WO-2025079609-A1 | Method for producing platelet-rich plasma | Inactive | 12-Oct-2023 | ||
| EP-4527394-A1 | Novel method for preserving platelets | Pending | 16-May-2022 | C12N5/526 |
AdipoSeeds Signals
AdipoSeeds Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kohjin Bio | Corporation | Minority | ||
| Sysmex (Diagnostic Equipment) | Corporation | Minority | ||
| Toho Holdings | Holding Company | Minority | ||
| DCI Partners | Venture Capital | Minority | ||
| Gemseki | Corporate Venture Capital | Minority |
AdipoSeeds FAQs
-
When was AdipoSeeds founded?
AdipoSeeds was founded in 2016.
-
Where is AdipoSeeds headquartered?
AdipoSeeds is headquartered in Tokyo, Japan.
-
What is the size of AdipoSeeds?
AdipoSeeds has 11 total employees.
-
What industry is AdipoSeeds in?
AdipoSeeds’s primary industry is Biotechnology.
-
Is AdipoSeeds a private or public company?
AdipoSeeds is a Private company.
-
What is AdipoSeeds’s current revenue?
The current revenue for AdipoSeeds is .
-
How much funding has AdipoSeeds raised over time?
AdipoSeeds has raised $11.6M.
-
Who are AdipoSeeds’s investors?
Kohjin Bio, Sysmex (Diagnostic Equipment), Toho Holdings, DCI Partners, and Gemseki are 5 of 15 investors who have invested in AdipoSeeds.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process